ACUTE BARORECEPTOR RESETTING IN HYPERTENSION
高血压时压力感受器急性重置
基本信息
- 批准号:3351067
- 负责人:
- 金额:$ 7.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-01 至 1990-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The arterial baroreceptors play a major role in the regulation of
arterial blood pressure in acute cardiovascular stresses such as
hemorrhage and in pathophysiologic states such as hypertension.
Activation of the arterial baroreceptors during a rise in arterial
pressure provokes a reflex inhibition of sympathetic activity and a
buffering of the rise in arterial pressure. The level of arterial
pressure at which these receptors will fire and their sensitivity to
changes in pressure is therefore an important determinant of the
neural regulation of arterial pressure. For example, in
hypertensive states, these baroreceptors are "reset" so that they
fire at a higher pressure and their sensitivity is reduced,
contributing to the sustained elevation of arterial pressure
(chronic resetting). This phenomenon of resetting also occurs in
normotensive animals following temporary elevations of arterial
pressure over a period of 10-15 minutes (acute resetting). The
purpose of the proposed studies is to examine: 1) the relative
degree of acute resetting of baroreceptors with myelinated and
unmyelinated afferent fibers; 2) the possible contribution of
circulating peptides (angiotensin II and vasopressin) to acute
resetting of aterial baroreflexes; 3) regional differences in
sympathetic outflow in response to brief changes (10-15 min.) in
arterial pressure; 4) the central nervous system response to brief
changes in afferent baroreceptor input, and 5) differences
between normotensive and hypertensive animals in any of the
above responses. Single unit baroreceptor discharge will be
recorded in both myelinated and unmyelinated afferent fibers and
responses to acute changes in pulsatile pressure will be examined.
Efferent sympathetic nerve activity will be recorded and reflex
control of regional sympathetic outflow (lumbar & renal) will be
assessed following brief alterations in the prevailing pressure. In
order to assess the contribution of circulating peptides to these
responses, the experiments will be repeated in the presence of
blockers of vasopressin and the renin-angiotensin system. Central
mechanisms will be examined by manipulating the central
afferent input (electrical stimulation of afferent nerves) and
observing the effects on reflex control of efferent sympathetic
nerve activity. Comparison of responses in normotensive and
hypertensive animals should yield insight into both physiologic and
pathophysiologic mechanisms involved in the reflex neural-
humoral control of the circulation.
动脉压力感受器在调节动脉压力中起主要作用。
急性心血管应激时的动脉血压,
出血和病理生理状态如高血压。
在动脉压升高期间动脉压力感受器的激活
压力引起交感神经活动的反射抑制,
缓冲动脉压的上升。 动脉水平
这些感受器的压力和它们对
因此,压力的变化是一个重要的决定因素
动脉压的神经调节 例如在
在高血压状态下,这些压力感受器被“重置”,
在更高的压力下点火并且它们的灵敏度降低,
导致动脉压持续升高
(慢性重置)。 这种重置现象也发生在
血压正常的动物在动脉暂时升高后
压力超过10-15分钟(急性重置)。 的
研究的目的是:(1)相对
压力感受器的急性重置程度,
无髓传入纤维; 2)可能的贡献
循环肽(血管紧张素II和加压素),以急性
动脉压力反射的重调定; 3)
交感神经流出对短暂变化的反应(10-15分钟)在
动脉压; 4)中枢神经系统对短暂
传入压力感受器输入的变化,以及5)差异
正常血压和高血压动物之间的任何
以上回答。 单个单位压力感受器放电将
记录在有髓和无髓传入纤维,
将检查对脉动压力的急性变化的反应。
传出交感神经活动将被记录和反射
将控制区域交感神经流出(腰和肾)
在主要压力发生短暂变化后进行评估。 在
为了评估循环肽对这些的贡献,
响应,实验将在以下情况下重复:
血管加压素和肾素-血管紧张素系统的阻断剂。 中央
机制将通过操纵中央
传入输入(传入神经的电刺激)和
观察对传出交感神经反射控制的影响
神经活动 血压正常和
高血压动物应该了解生理和
病理生理机制参与反射神经-
体液对血液循环的控制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheryl M Heesch其他文献
Cheryl M Heesch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cheryl M Heesch', 18)}}的其他基金
Central nervous system plasticity in sympathoinhibition in pregnancy
妊娠交感神经抑制中的中枢神经系统可塑性
- 批准号:
7653338 - 财政年份:2009
- 资助金额:
$ 7.01万 - 项目类别:
Central nervous system plasticity in sympathoinhibition in pregnancy
妊娠交感神经抑制中的中枢神经系统可塑性
- 批准号:
8235901 - 财政年份:2009
- 资助金额:
$ 7.01万 - 项目类别:
Central nervous system plasticity in sympathoinhibition in pregnancy
妊娠交感神经抑制中的中枢神经系统可塑性
- 批准号:
8051535 - 财政年份:2009
- 资助金额:
$ 7.01万 - 项目类别:
Central nervous system plasticity in sympathoinhibition in pregnancy
妊娠交感神经抑制中的中枢神经系统可塑性
- 批准号:
7848328 - 财政年份:2009
- 资助金额:
$ 7.01万 - 项目类别:
STEROID HORMONE METABOLITES & NEURAL CIRCULATORY CONTROL
类固醇激素代谢物
- 批准号:
2028243 - 财政年份:1985
- 资助金额:
$ 7.01万 - 项目类别:
相似海外基金
The role of antihypertensive agents in renal and vascular complications in a model of hypertension and diabetes
抗高血压药物在高血压和糖尿病模型中肾脏和血管并发症中的作用
- 批准号:
nhmrc : 145854 - 财政年份:2001
- 资助金额:
$ 7.01万 - 项目类别:
NHMRC Postgraduate Scholarships
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
6125791 - 财政年份:1997
- 资助金额:
$ 7.01万 - 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
2487342 - 财政年份:1997
- 资助金额:
$ 7.01万 - 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
2839029 - 财政年份:1997
- 资助金额:
$ 7.01万 - 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
6330091 - 财政年份:1997
- 资助金额:
$ 7.01万 - 项目类别:
Antihypertensive Agents of Kudzu: Possible Chemical Utilization of a Southeastern Pest Vine
葛根的抗高血压剂:东南部害虫藤蔓的可能化学利用
- 批准号:
7905238 - 财政年份:1979
- 资助金额:
$ 7.01万 - 项目类别:
Standard Grant